Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Direct Oral Anticoagulants for the Treatment of Mural Thrombus

NCT04153591 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT04153591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04153591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Direct Oral Anticoagulants for the Treatment of Mural Thrombus
Lead sponsor
Methodist Health System
Phase
Observational
Overall status
Completed
Start date
November 5, 2019
Completion date
June 22, 2020
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction